{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:30:56Z","timestamp":1780929056391,"version":"3.54.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Aims:<\/jats:bold> To determine financial implications of implementing cardiac magnetic resonance imaging (CMR) in the diagnostic pathway of a population with unexplained acute myocardial injury and normal coronary angiography.<\/jats:p><jats:p><jats:bold>Methods and Results:<\/jats:bold> We performed a focused cost-benefit analysis using a hypothetical population of 2,000 patients with unexplained acute myocardial injury and normal coronary angiography divided into two groups to receive either standard or CMR guided management over a 10-year period. As healthcare practice and costs considerably vary geographically and over time, an algorithm with 15 key variables was developed to permit user-defined calculations of cost-benefit and other analyses. Using current UK costs, routine use of CMR increases healthcare spending by 14% per patient in the first year. After 7 years, CMR guided practice is cost neutral, reducing cost by 3% per patient 10 years following presentation. In addition, CMR -guided therapy results in 7 fewer myocardial infarctions and 14 fewer major bleeding events per 1,000 patients over a 10-year period. The three most sensitive variables were, in decreasing order, the cost of CMR, the cost of ticagrelor and the percentage of the population with MI requiring DAPT.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Routine use of CMR in patients with unexplained acute myocardial injury and normal coronary angiography is associated with cost reductions in the medium to long term. The initial higher cost of CMR is offset over time and delivers a more personalized and higher quality of care.<\/jats:p>","DOI":"10.3389\/fcvm.2021.749668","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T23:18:28Z","timestamp":1634771908000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["A Cost Analysis of Cardiac Magnetic Resonance Imaging in the Diagnostic Pathway of Patients Presenting With Unexplained Acute Myocardial Injury and Culprit-Free Coronary Angiography"],"prefix":"10.3389","volume":"8","author":[{"given":"Theodore","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Friebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma","family":"Uchegbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidi A.","family":"Mohiddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen E.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archinte.1951.03810110049005","article-title":"Burchell H, Edwards J. Myocardial infarction with and without acute coronary occlusion","volume":"88","year":"1951","journal-title":"AMA Arch Intern Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.114.011201","article-title":"Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries","volume":"131","author":"Pasupathy","year":"2015","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease","volume":"135","author":"Lindahl","year":"2017","journal-title":"Circulation."},{"key":"B4","doi-asserted-by":"publisher","first-page":"ehz748.0147","DOI":"10.1093\/eurheartj\/ehz748.0147","article-title":"2389 Survival after myocardial infarction with non-obstructive coronary arteries (MINOCA) - a comprehensive systematic review and meta-analysis","volume":"40","author":"Pasupathy","year":"2019","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1136\/heartjnl-2019-316295","article-title":"Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries","volume":"106","author":"V\u00e1g\u00f3","year":"2020","journal-title":"Heart."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.jcmg.2018.12.023","article-title":"Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries","volume":"12","author":"Dastidar","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10554-011-9879-1","article-title":"Cardiac magnetic resonance imaging for the diagnosis of patients presenting with chest pain, raised troponin, and unobstructed coronary arteries","volume":"28","author":"Gerbaud","year":"2011","journal-title":"Int J Cardiovasc Imaging."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jcmg.2016.11.010","article-title":"Myocardial infarction with nonobstructed coronary arteries","volume":"10","author":"Dastidar","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"B9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/eurheartj\/ehw149","article-title":"ESC working group position paper on myocardial infarction with non-obstructive coronary arteries","volume":"38","author":"Agewall","year":"2016","journal-title":"Eur Heart J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa909","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","author":"Collet","year":"","journal-title":"Eur Heart J."},{"key":"B12","unstructured":"EnglandN\n          NHS England National Cost Collection for the NHS2020"},{"key":"B13","unstructured":"Drug Tariff2020"},{"key":"B14","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","article-title":"Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial","volume":"392","author":"Vranckx","year":"2018","journal-title":"Lancet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Study Collaborative Group. Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","year":"2018","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM200111153452023","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med."},{"key":"B18","unstructured":"NHSDigital\n          Hospital Admitted Patient Care Activity 2019-202020"},{"key":"B19","doi-asserted-by":"publisher","first-page":"ehz747.0475","DOI":"10.1093\/eurheartj\/ehz747.0475","article-title":"P878 Prevalence and prognosis of patients with myocardial infarction with nonobstructive coronary arteries: a nationwide registry based study","volume":"40","author":"Janosi","year":"2019","journal-title":"Eur Heart J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.749668\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T23:18:57Z","timestamp":1634771937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.749668\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":19,"alternative-id":["10.3389\/fcvm.2021.749668"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.749668","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"article-number":"749668"}}